Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 19,992 shares at $54.12 ($1.1M) on 2022-11-15, disclosed to the SEC on 2022-11-16.
Open-market sale of $1.1M HALO by SVP, CHIEF TECHNICAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.12 | 6,877 | $372K | 34.4% |
| 2 | $54.12 | 6,877 | $372K | 34.4% |
| 3 | $54.14 | 3,115 | $169K | 15.6% |
| 4 | $54.14 | 3,115 | $169K | 15.6% |
| 5 | $54.61 | 8 | $437 | 0.0% |
| Total | $54.13 avg | 19,992 |
| $1.1M |
| 100% |
| Filing → |
| HALO | SELL | 2024-09-18 | $1.9M | — | Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |